How are VKTX long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the VKTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 80.32%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$447.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a VKTX long call?

The breakeven for the VKTX long call priced on this page is roughly $43.48 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VKTX market-implied 1-standard-deviation expected move is approximately 23.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current VKTX implied volatility affect this long call?

VKTX ATM IV is at 80.32% with IV rank near 27.63%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

VKTX Long Call Strategy

VKTX (Viking Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy.

VKTX (Viking Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.42B, a beta of 0.68 versus the broader market, a 52-week range of 22.959-43.15, average daily share volume of 2.3M, a public-listing history dating back to 2015, approximately 45 full-time employees. These structural characteristics shape how VKTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.68 indicates VKTX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on VKTX?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current VKTX snapshot

As of June 30, 2026, spot at $39.46, ATM IV 80.32%, IV rank 27.63%, expected move 23.03%. The long call on VKTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.

Why this long call structure on VKTX specifically: VKTX IV at 80.32% is on the cheap side of its 1-year range, which favors premium-buying structures like a VKTX long call, with a market-implied 1-standard-deviation move of approximately 23.03% (roughly $9.09 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VKTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on VKTX should anchor to the underlying notional of $39.46 per share and to the trader's directional view on VKTX stock.

VKTX long call setup

The VKTX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VKTX near $39.46, the first option leg uses a $39.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VKTX chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VKTX shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$39.00	$4.48

VKTX long call risk and reward

Net Premium / Debit: -$447.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$447.50
Breakeven(s): $43.48
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

VKTX long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on VKTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$447.50
$8.73	-77.9%	-$447.50
$17.46	-55.8%	-$447.50
$26.18	-33.7%	-$447.50
$34.90	-11.5%	-$447.50
$43.63	+10.6%	+$15.36
$52.35	+32.7%	+$887.73
$61.08	+54.8%	+$1,760.10
$69.80	+76.9%	+$2,632.47
$78.52	+99.0%	+$3,504.85

When traders use long call on VKTX

Long calls on VKTX express a bullish thesis with defined risk; traders use them ahead of VKTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

VKTX thesis for this long call

The market-implied 1-standard-deviation range for VKTX extends from approximately $30.37 on the downside to $48.55 on the upside. A VKTX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current VKTX IV rank near 27.63% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VKTX at 80.32%. As a Healthcare name, VKTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VKTX-specific events.

VKTX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VKTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VKTX alongside the broader basket even when VKTX-specific fundamentals are unchanged. Long-premium structures like a long call on VKTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current VKTX chain quotes before placing a trade.

Frequently asked questions

What is a long call on VKTX?: A long call on VKTX is the long call strategy applied to VKTX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With VKTX stock trading near $39.46, the strikes shown on this page are snapped to the nearest listed VKTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VKTX long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the VKTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 80.32%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$447.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VKTX long call?: The breakeven for the VKTX long call priced on this page is roughly $43.48 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VKTX market-implied 1-standard-deviation expected move is approximately 23.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on VKTX?: Long calls on VKTX express a bullish thesis with defined risk; traders use them ahead of VKTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current VKTX implied volatility affect this long call?: VKTX ATM IV is at 80.32% with IV rank near 27.63%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.